GOVX
GeoVax Labs IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$12.64M
P/E Ratio
—
EPS
$-13.82
Beta
3.35
52W High
$34.75
52W Low
$0.96
50-Day MA
$1.46
200-Day MA
$7.85
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
9.65
PEG Ratio
0.00
About GeoVax Labs Inc
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using a modified vaccinia ankara virus-like particle vaccine platform. The company is headquartered in Smyrna, Georgia.
Fundamentals
| Revenue (TTM) | 852,280 |
| Gross Profit (TTM) | $-17.27M |
| EBITDA | $-21.44M |
| Operating Margin | -2523.00% |
| Return on Equity | -509.00% |
| Return on Assets | -194.60% |
| Revenue/Share (TTM) | $0.64 |
| Book Value | $0.17 |
| Price-to-Book | 25.53 |
| Price-to-Sales (TTM) | 14.83 |
| EV/Revenue | 13.76 |
| EV/EBITDA | 15.26 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -100.00% |
| Shares Outstanding | $3.47M |
| Float | $3.47M |
| % Insiders | 0.10% |
| % Institutions | 9.85% |
Historical Volatility
HV 10-Day
145.29%
HV 20-Day
109.87%
HV 30-Day
96.66%
HV 60-Day
86.14%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($77.50 target)
3
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026